|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 401/14 | |
| C07D 405/14 | |||
| C07D 401/12 | |||
| A61K 31/513 | |||
| A61K 31/501 | |||
| A61K 31/497 | |||
| A61P 25/00 |
| (11) | Number of the document | 3013813 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14739554.5 |
| Date of filing the European patent application | 2014-06-13 | |
| (97) | Date of publication of the European application | 2016-05-04 |
| (45) | Date of publication and mention of the grant of the patent | 2019-04-03 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2014/062217 |
| Date | 2014-06-13 |
| (87) | Number | WO 2014/207601 |
| Date | 2014-12-31 |
| (30) | Number | Date | Country code |
| 201361840144 P | 2013-06-27 | US |
| (72) |
BRODNEY, Michael Aaron, US
DAVOREN, Jennifer Elizabeth, US
DOUNAY, Amy Beth, US
EFREMOV, Ivan Viktorovich, US
GRAY, David Lawrence Firman, US
GREEN, Michael Eric, US
HENDERSON, Jaclyn Louise, US
LEE, Chewah, US
MENTE, Scot Richard, US
O`NEIL, Steven Victor, US
ROGERS, Bruce Nelsen, US
ZHANG, Lei, US
|
| (73) |
Pfizer Inc.,
235 East 42nd Street, New York, NY 10017,
US
|
| (54) | HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS |
| HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS |